Vault-13

TEVOGEN BIO HLDGS INC

COM · CUSIP 88165K101

6 institutional holders
6,779,1626.8m shares reported held*
$30.7mreported value*

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.53.

Biggest buyers

Biggest sellers

None

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Saadi Ryan H. 13D · may seek influence -2.3 pts · filed 2026-07-14
Stated purposeItem 4 of the Schedule 13D is hereby amended and supplemented by adding the following: The information set forth in Items 3 and 6 of this Amendment is incorporated into this Item 4 by reference. Full filing
59.7% -2.3 pts 3.7m 2026-07-14

Holders, Q1 2024

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Portland Global Advisors LLC 2.96% of their portfolio PORTLAND, ME 5,782,2095.8m $21.7m $21.7m 2.96% New
2 CANTOR FITZGERALD, L. P. 0.66% of their portfolio NEW YORK, NY 650,000650.0k $2.8m $2.8m 0.66% New
3 Polar Asset Management Partners Inc. 0.17% of their portfolio TORONTO, A6 334,615334.6k $6.2m $6.2m 0.17% New
4 HRT FINANCIAL LP 0.00% of their portfolio NEW YORK, NY 12,27812.3k $45.0k $45.0k 0.00% New
5 JPMORGAN CHASE & CO 0.00% of their portfolio NEW YORK, NY 6060 $224 $224 0.00% New
6 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% New